clinical trial · NCT04158258
A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America
Hoffmann-La Roche·—·active not recruiting·n = 2,907
Breast CancerBevacizumabTrastuzumabAdo-trastuzumab emtamsinePertuzumabAtezolizumabCapecitabine
brief summary
A Prospective, Multicenter, Non-Interventional Study of Primary Data Collection, Designed to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcomes in Patients with Breast Cancer in Latin America.
started
Feb 21, 2020
primary completion
Jun 30, 2026
completion
Jun 30, 2026
last updated
Apr 23, 2026
official title
A STUDY TO OBSERVE PATIENTS CHARACTERISTICS, TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH NEWLY DIAGNOSED BREAST CANCER IN LATIN AMERICA
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol